ST
GILD icon

Sageworth Trust’s Gilead Sciences GILD Stock Holding History

Sageworth Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,832
Closed -$425K – 190
2025
Q3 		$425K Buy
+3,832
New +$436K 0.02% 172
2020
Q3 		– Sell
-8
Closed -$1K – 255
2020
Q2 		$1K Buy
+8
New +$613 ﹤0.01% 189
2019
Q1 		– Sell
-8
Closed -$1K – 277
2018
Q4 		$1K Buy
+8
New +$559 ﹤0.01% 141
2018
Q2 		– Sell
-146
Closed -$11K – 166
2018
Q1 		$11K Buy
+146
New +$11.6K ﹤0.01% 87
2017
Q3 		– Sell
-1,190
Closed -$84K – 83
2017
Q2 		$84K Buy
1,190
+990
+495% +$65.9K 0.02% 40
2017
Q1 		$14K Buy
+200
New +$14.1K ﹤0.01% 66

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sageworth Trust's GILD Position: Q4 2025 in Review

Sageworth Trust sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 3,832 shares — an estimated $425K sold.

Sageworth Trust first reported a position in GILD in Q1 2017 and held it in 6 quarters. The position peaked at $425K in Q3 2025. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Sageworth Trust reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Sageworth Trust sold 3,832 Gilead Sciences shares in Q4 2025, an estimated $425K.
  • Sageworth Trust first reported a position in Gilead Sciences in Q1 2017 and held it in 6 quarters.
  • Sageworth Trust's Gilead Sciences position peaked at $425K in Q3 2025.
  • 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Sageworth Trust's 13F filing for Q4 2025, filed 3 Feb 2026.